Posted July 3, 2020
On Mar. 27, 2020, the U.S. Food and Drug Administration (FDA) issued Emergency Use Authorization (EUA) to pharmaceutical and medical devices company Abbott Laboratories, Inc. of Abbott Park, Illinois for a rapid diagnostic test for the SARS-CoV-2 virus known as ID NOW.1 2 3 “We know how important it is to get point-of-care tests out in the field quickly. These tests that can give results quickly can be a game changer in diagnosing COVID-19,” FDA commissioner Steve Hahn said. Read more.